Trial NCT00310388

View at ClinicalTrials.gov 
Org. Study IDs: VRX-RET-E22-304
Secondary IDs: 2006-000956-42 RTG115097

Last trial update was posted on 2018-11-15

MeSH Interventions

Ezogabine

MeSH Conditions

Epilepsy

Other Conditions


Stopping Reasons

No longer any benefit in collecting data since retigabine has been withdrawn from market.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID